The Indy Autonomous Challenge Presented by Bridgestone Returns to Goodwood Festival of Speed in July 2024
11.6.2024 17:00:00 EEST | Business Wire | Press release
Returning to showcase the World’s Fastest Autonomous Racecar, the Indy Autonomous Challenge (IAC), presented by Bridgestone, will take on the hillclimb at the Goodwood Festival of Speed presented by Mastercard from July 11th to July 14th, 2024. This year, the IAC’s AV-24 fully autonomous racecar will be piloted by software from the PoliMOVE-MSU team, with support from the UNIMORE Racing team.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611138772/en/
The world's fastest autonomous racecar with an AI pilot coded by students from PoliMOVE-MSU team races on Goodwood Hill. Credit Indy Autonomous Challenge. (Photo: Business Wire)
The IAC has developed the AV-24, a fully autonomous racecar utilizing a Dallara chassis used in the Indy NXT series, and outfitted with a state-of-the-art robotics platform developed with leading autonomous hardware and software providers. To date, the IAC has organized autonomous racing competitions gathering 10 teams comprised of 18 universities at prestigious venues such as the Indianapolis Motor Speedway, Las Vegas Motor Speedway, Texas Motor Speedway, and Monza F1 Circuit—affectionately known as the Temple of Speed. The 2024 Festival of Speed marks the Indy Autonomous Challenge’s competitive debut in the UK, promising to test the technology in new and challenging ways.
Since its inception in 2021, the Indy Autonomous Challenge and its university teams have set several world records for high-speed ground-based autonomy:
- Autonomous land speed record of 192.2 mph
- Highest on-track speed of 180 mph
- Fastest head-to-head overtake on-track at 177 mph
- Most miles of autonomous racing accumulated: 9,000 miles.
Last year the Indy Autonomous Challenge was introduced to Goodwood in 2023 as part of Future Lab presented by Randox, illustrating the IAC’s significant role in advancing automotive driving technology through global events. Additionally, the Technical University of Munich used their autonomous racecar to conduct a low-speed scan of the Goodwood hill, crafting a digital twin of the course that will help enable this year’s fully autonomous hillclimb.
Paul Mitchell, Chairman and President of the Indy Autonomous Challenge, expressed enthusiasm about the upcoming event, stating, “We are eager to undertake the unique challenges presented by the Goodwood Hillclimb. Unlike the familiar ovals and F1 road courses, Goodwood’s Hillclimb will challenge the precision of sensor perception, GPS localization, vehicle dynamics, and path planning in new ways, providing a historical backdrop to showcase the future of high-speed autonomous mobility and the innovative university teams behind it.”
The event, part of Goodwood’s FOS TECH program, will highlight the latest in automotive technology and alternative fuels, integrating the Future Lab and STEM programs targeted at young people eager to participate in future robotics. IAC university teams’ capabilities will be showcased as they attempt an autonomous world record on the Goodwood hill. Autonomous racing will not only entertain but also offer insights and learnings towards the future of mobility, demonstrating how AI drivers will revolutionize vehicle safety and efficiency on public roads and within supply chains.
The Duke of Richmond, founder of the Festival of Speed, commented on the festival’s role in showcasing technological innovation: “This year, our new FOS TECH ethos will bring together our future technology and mobility content. Whether exploring Future Lab presented by Randox, Electric Avenue, or enjoying content on the Hill, visitors to the Festival of Speed can experience the work of groundbreaking innovators and their vision for tomorrow’s world.”
Sara Correa, Chief Marketing Officer for Bridgestone in the Americas, Europe, Middle East and Africa (EMEA) added, “What really matters is working together to collaboratively develop and advance the future of mobility. Bridgestone is proud to partner with the IAC and its young engineers to test and improve autonomous technologies through opportunities like the Goodwood Hillclimb. Motorsports are the ultimate challenge, and the learnings we gather here can be applied to the sustainable solutions we develop for society and our customers.”
Participating teams: PoliMOVE-MSU - Comprised of members from Politecnico di Milano (Italy), Michigan State University (Michigan), with the support of UNIMORE Racing - University of Modena and Reggio Emilia (Italy)
The IAC’s appearance at Goodwood Festival of Speed will be the first time that an exhibitor has graduated from Future Lab to the Hillclimb. This year’s event will also feature engaging educational sessions, where attendees can explore future technologies such as autonomous vehicles, drones, robots, augmented and virtual reality, generative AI, sensor fusion, and the Internet of Things. These topics will be the focus of a Q&A session in collaboration with Durham University's solar-powered electric car team, which has also worked with Bridgestone to advance sustainable mobility.
Earlier in June, the IAC conducted a series of training sessions on the Goodwood Hillclimb, performing fully autonomous runs of the hill, reaching speeds greater than 177 kph (110mph). Video and photo footage of the training sessions and racecar livery renders dedicated to media use can be found here.
About the IAC: The Indy Autonomous Challenge (IAC) is a non-profit corporation based in Indianapolis, Indiana (USA) that organizes racing competitions among 10 university-affiliated teams representing 18 universities from around the world. Teams program AI drivers to pilot fully autonomous racecars and compete in a series of history-making events at iconic tracks. Based in Indiana, the IAC is working to establish a hub for performance automation in the state and is harnessing the power of innovative competitions to attract the best and the brightest minds from around the globe to further state-of-the-art technology in the safety and performance of autonomous vehicles. The IAC started as a $1 million prize competition with 31 university teams signing up to compete more than three years ago, representing top engineering and technology programs from 15 U.S. states and 11 countries. Follow the IAC @IndyAChallenge on LinkedIn, Twitter, Instagram, Facebook, and YouTube.
About Bridgestone: Bridgestone is a global leader in tires and rubber building on its expertise to provide solutions for safe and sustainable mobility. Headquartered in Tokyo, the company employs approximately 130,000 people globally and conducts business in more than 150 countries and territories worldwide. Bridgestone offers a diverse product portfolio of premium tires and advanced solutions backed by innovative technologies, improving the way people around the world move, live, work and play.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240611138772/en/
Contacts
Marc Ferlet
marc.ferlet@indyautonomouschallenge.com
USA: +1 317 662 5070
FR: +33 6 79 16 96 26
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 08:00:00 EEST | Press release
Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufacturing site. All other aspects of the BLA, including safety- and efficacy-related parts, did not solicit deficiencies to be addressed. The FDA made observations during the PLI for which Galderma is putting in place corrective and preventive actions. Galderma will also be seeking further guidance through continued open dialogue with the FDA toward resolution of the relevant observations. Galderma plans to rapidly respond to the CRL and advancing RelabotulinumtoxinA in the U.S. remains a top priority. The ob
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 04:45:00 EEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom